Title | Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. |
Publication Type | Journal Article |
Year of Publication | 2005 |
Authors | Chen J, Tung C-H, Allport JR, Chen S, Weissleder R, Huang PL |
Journal | Circulation |
Volume | 111 |
Issue | 14 |
Pagination | 1800-5 |
Date Published | 2005 Apr 12 |
ISSN | 1524-4539 |
Keywords | Animals, Diagnostic Imaging, Fluorescent Dyes, Infrared Rays, Leukocytes, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Mice, Molecular Probe Techniques, Molecular Probes, Myocardial Infarction, Neutrophils, Up-Regulation |
Abstract | BACKGROUND: We used a molecular probe activated by protease cleavage to image expression of matrix metalloproteinases (MMPs) in the heart after myocardial infarction. METHODS AND RESULTS: We synthesized and characterized a near-infrared fluorescent (NIRF) probe that is activated by proteolytic cleavage by MMP2 and MMP9. The NIRF probe was injected into mice at various time points up to 4 weeks after myocardial infarction induced by ligation of the left anterior descending coronary artery. NIRF imaging of MMP activity increased in the infarct region, with maximal expression at 1 to 2 weeks, persisting to 4 weeks. Zymography and real-time polymerase chain reaction analysis showed that MMP9 expression is increased at 2 to 4 days, and MMP2 expression is increased at 1 to 2 weeks. Dual-label confocal microscopy showed colocalization of NIRF imaging with neutrophils on day 2, and flow cytometric analysis confirmed that NIRF signal is associated with leukocytes in the infarct zone. CONCLUSIONS: This study demonstrates that the activity of MMPs in the myocardium may be imaged by use of specific activity-dependent molecular probes. |
DOI | 10.1161/01.CIR.0000160936.91849.9F |
Alternate Journal | Circulation |
PubMed ID | 15809374 |
PubMed Central ID | PMC3733536 |
Grant List | HL-52818 / HL / NHLBI NIH HHS / United States CA-86355 / CA / NCI NIH HHS / United States R01 HL057818-09 / HL / NHLBI NIH HHS / United States R01 HL057818 / HL / NHLBI NIH HHS / United States P50 CA086355 / CA / NCI NIH HHS / United States |
Related Institute:
Molecular Imaging Innovations Institute (MI3)